Sunday, April 22, 2018
 
 
Company News: Page (1) of 1 - 04/16/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Innovation in Lung Cancer Market 2018, Strategic Insight, Advance Technologies, Recent Development Trends and Future Demand Till 2023

(April 16, 2018)


"Lung Cancer Market"
MRFR Press Release/- Market research future published a cooked research report on global Lung Cancer Market. The Global Lung Cancer market is expected to grow with a CAGR of 13.5% during the period 2017 to 2023.

The International Lung Cancer Market is growing steadily. The global lung cancer market on the basis of region comprises of North America, Europe, Asia Pacific and Middle East & Africa. The global market for Lung Cancer is growing with the CAGR of 13.5% during the forecast period from 2017-2023. NSCLC is the most common type of lung cancer globally. The global Lung Cancer market reached USD 36929.8 million in 2023 from 15219.7 million in 2016. Europe region captured the second largest market globally and is expected to reach USD 8,536.3 million by 2023 due to the growing demand and need for lung cancer drugs, and the growing prevalence of lung cancer.

Lung Cancer Market Segmentation:

Global Lung Cancer Market has been segmented on the basis of types which comprises of push button Lung Cancer, pressure activated Lung Cancer and side button Lung Cancer. On the basis of end user, it comprises of hospitals & clinics, diagnostic centers and pathology laboratories, home diagnostics and other end users.

Get Exclusive Sample Report @ https://www.marketresearchfuture.com/sample_request/1185 .

Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in lung tissue with symptoms such as coughing, weight loss, fatigue and chest pain. The two types of lung cancers are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The NSCLC type accounts for almost 80% of the cancers with NSCLC representing the remaining. The cure rates for the two types of lung cancers exchange their positions with the SCLC being the most malignant. The cure rates also depend on the stage of cancer detection with rates varying by 55% for first stage to just 1% for stage four.

Almost 85% of cases of lung cancer are due to long-term tobacco smoking. Cigarette smoke contains at least 73 known carcinogens. Other factors causing lung cancer are genetic factors and exposure to triggers and carcinogens such as radon gas, asbestos, radioactive materials, second-hand smoke, or air pollution. It has also been demonstrated that passive smokers have a 20–30% increase in risk.

The treatments for lung cancer include surgery, chemotherapy, and radiotherapy with NSCLC responding better to surgery and SCLC usually responding better to chemotherapy and radiotherapy. The main drivers of lung cancer are the growing environmental pollution and smoking. The rise in the cases of lung cancers in females due to rising number of female smokers will drive the market up. Another driver is the greater screening rates with a sizable portion of lung cancer are detected during screening for other diseases.

Key Players for Global Lung Cancer Market:

Some of the key players in this market are: F. Hoffmann-La Roche AG, Novartis, PFIZER INC, Merck & Co., Inc., BRISTOL-MYERS SQUIBB, ELI Lilly and Company, Sanofi and others.

Get Discount @ https://www.marketresearchfuture.com/check-discount/1185 .

Major TOC for Lung Cancer Market Research Report - Global Forecast to 2023:

1 REPORT PROLOGUE

2 INTRODUCTION

2.1 Research Objective

2.2 Assumptions & Limitations

2.2.1 Assumptions

2.2.2 Limitations

2.3 Market Structure

3 RESEARCH METHODOLOGY

3.1 Primary Research

3.2 Secondary Research

4 PORTERS FIVE FORCES

4.1 Introduction

4.2 Bargaining Power Of Buyer

4.3 Bargaining Power Of Suppliers

4.3.1 Threat From Substitute

4.3.2 Threat From A New Entrant

4.3.3 Intensity Of Competitive Rivalry

….T.O.C continued

Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/1185 .

LIST OF TABLES

TABLE 1 LUNG CANCER DRUGS, PIPELINE 2016

TABLE 2 GLOBAL LUNG CANCER MARKET BY TYPES US$ MILLION (2014-2023)

TABLE 3 GLOBAL SCLC MARKET US$ MILLION (2014 & 2023)

TABLE 4 GLOBAL NSCLC MARKET US$ MILLION (2014 & 2023)

TABLE 5 GLOBAL LUNG CANCER MARKET BY TREATMENTS US$ MILLION (2014-2023)

LIST OF FIGURES

FIGURE 1 GLOBAL LUNG CANCER MARKET BY TYPES MARKET SHARE 2016 (%)

FIGURE 2 GLOBAL LUNG CANCER MARKET BY TREATMENTS MARKET SHARE 2016 (%)

FIGURE 3 GLOBAL LUNG CANCER MARKET BY END USERS MARKET SHARE 2016 (%)

FIGURE 4 GLOBAL LUNG CANCER MARKET BY REGION 2016 MARKET SHARE (%)

FIGURE 5 RESEARCH PROCESS

FIGURE 6 GLOBAL LUNG CANCER MARKET BY TYPES US$ MILLION (2014 & 2023)

& More…!

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact

Company Name: Market Research FutureContact Person: Akash Anand


Email: [email protected]
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune -
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/lung-cancer-market-1185



Source: www.abnewswire.com


Page: 1


Related Keywords:Business,Fitness,Health & Medicine,News & Current Affairs,Services,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines